Ido Laskov

919 total citations
59 papers, 652 citations indexed

About

Ido Laskov is a scholar working on Obstetrics and Gynecology, Reproductive Medicine and Surgery. According to data from OpenAlex, Ido Laskov has authored 59 papers receiving a total of 652 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Obstetrics and Gynecology, 21 papers in Reproductive Medicine and 15 papers in Surgery. Recurrent topics in Ido Laskov's work include Endometrial and Cervical Cancer Treatments (22 papers), Ovarian cancer diagnosis and treatment (18 papers) and Intraperitoneal and Appendiceal Malignancies (8 papers). Ido Laskov is often cited by papers focused on Endometrial and Cervical Cancer Treatments (22 papers), Ovarian cancer diagnosis and treatment (18 papers) and Intraperitoneal and Appendiceal Malignancies (8 papers). Ido Laskov collaborates with scholars based in Israel, Canada and United States. Ido Laskov's co-authors include Walter H. Gotlieb, Amber Yasmeen, Marie‐Claude Beauchamp, Nadav Michaan, Roy Kessous, Dan Grisaru, Liron Kogan, Charles‐André Philip, Susie Lau and Joseph B. Lessing and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Cancer and Fertility and Sterility.

In The Last Decade

Ido Laskov

52 papers receiving 646 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ido Laskov Israel 15 215 212 203 180 90 59 652
Ruifang An China 15 175 0.8× 198 0.9× 103 0.5× 120 0.7× 97 1.1× 58 628
H Mertens Netherlands 10 146 0.7× 209 1.0× 143 0.7× 179 1.0× 88 1.0× 22 738
Iztok Takač Slovenia 18 200 0.9× 127 0.6× 270 1.3× 175 1.0× 69 0.8× 101 881
Mohamad Nasir Shafiee Malaysia 17 174 0.8× 103 0.5× 202 1.0× 268 1.5× 67 0.7× 57 720
Mehmet Ali Vardar Türkiye 14 75 0.3× 161 0.8× 235 1.2× 220 1.2× 76 0.8× 72 636
Zhengyu Li China 13 92 0.4× 139 0.7× 127 0.6× 191 1.1× 30 0.3× 50 483
Stefanos Zervoudis Greece 11 134 0.6× 178 0.8× 96 0.5× 104 0.6× 49 0.5× 55 665
Norbert Winer France 12 204 0.9× 72 0.3× 286 1.4× 235 1.3× 232 2.6× 49 884
Sarikapan Wilailak Thailand 16 120 0.6× 242 1.1× 305 1.5× 311 1.7× 69 0.8× 59 870
Kerri S. Bevis United States 15 388 1.8× 402 1.9× 78 0.4× 170 0.9× 66 0.7× 47 985

Countries citing papers authored by Ido Laskov

Since Specialization
Citations

This map shows the geographic impact of Ido Laskov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ido Laskov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ido Laskov more than expected).

Fields of papers citing papers by Ido Laskov

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ido Laskov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ido Laskov. The network helps show where Ido Laskov may publish in the future.

Co-authorship network of co-authors of Ido Laskov

This figure shows the co-authorship network connecting the top 25 collaborators of Ido Laskov. A scholar is included among the top collaborators of Ido Laskov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ido Laskov. Ido Laskov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Michaan, Nadav, et al.. (2025). Identifying risk factors for postoperative complications following staging surgery for endometrial cancer. Journal of Gynecology Obstetrics and Human Reproduction. 54(6). 102949–102949.
2.
Raz, Yael, Uriel Katz, Ido Laskov, et al.. (2025). Cytoreductive surgery in advanced epithelial ovarian cancer: a real-world analysis guided by clinical variables, homologous recombination, and BRCA status. International Journal of Gynecological Cancer. 35(6). 101809–101809.
3.
Raz, Yael, Ido Laskov, Nadav Michaan, et al.. (2025). Survivorship in advanced ovarian cancer: a prognostic model for overall survival and risk of recurrence. The Oncologist. 30(9).
4.
Grisaru, Dan, et al.. (2025). Risk factors for hospital readmission following staging surgery for endometrial cancer. European Journal of Obstetrics & Gynecology and Reproductive Biology. 316. 114792–114792.
5.
Laskov, Ido, Nadav Michaan, Xing Zeng, et al.. (2024). The Impact of Intrauterine Manipulators on Outcome and Recurrence Patterns of Endometrial Cancer Patients Undergoing Minimally Invasive Surgery. Journal of Women s Health. 33(3). 355–363. 1 indexed citations
6.
7.
Laskov, Ido, et al.. (2023). Does gas insufflation during oncologic laparoscopic surgery cause dissemination of malignant cells?. European Journal of Gynaecological Oncology. 2 indexed citations
8.
Laskov, Ido, Shira Peleg Hasson, Aviad Cohen, et al.. (2023). Effect of BMI change on recurrence risk in patients with endometrial cancer. International Journal of Gynecological Cancer. 33(5). 713–718. 6 indexed citations
9.
Michaan, Nadav, Einat Even‐Sapir, Tatiana Rabin, et al.. (2023). Prognostic significance of delayed complete metabolic response on PET/CT after primary chemoradiation treatment of cervical cancer. International Journal of Gynecological Cancer. 33(11). 1695–1701.
10.
Michaan, Nadav, Aviad Cohen, Ariel Many, et al.. (2022). Average maternal hemoglobin decline after first elective cesarean section compared to higher order cesarean sections. International Journal of Gynecology & Obstetrics. 160(1). 79–84.
11.
Horn, Galit, Tova Waks, Ido Laskov, et al.. (2022). Comparing Intraperitoneal and Intravenous Personalized ErbB2CAR-T for the Treatment of Epithelial Ovarian Cancer. Biomedicines. 10(9). 2216–2216. 9 indexed citations
12.
Cohen, Aviad, et al.. (2022). Incidence of endometrial carcinoma in patients with endometrial intraepithelial neoplasia versus atypical endometrial polyp. International Journal of Gynecological Cancer. 33(1). 35–41. 4 indexed citations
13.
Michaan, Nadav, Moshe Leshno, Yoni Cohen, et al.. (2021). Preimplantation genetic testing for BRCA gene mutation carriers: a cost effectiveness analysis. Reproductive Biology and Endocrinology. 19(1). 5 indexed citations
14.
Michaan, Nadav, Moshe Leshno, Tamar Safra, et al.. (2020). Cost Effectiveness of Whole Population BRCA Genetic Screening for Cancer Prevention in Israel. Cancer Prevention Research. 14(4). 455–462. 13 indexed citations
15.
Kessous, Roy, Michel D. Wissing, Sabrina Piedimonte, et al.. (2020). CA‐125 reduction during neoadjuvant chemotherapy is associated with success of cytoreductive surgery and outcome of patients with advanced high‐grade ovarian cancer. Acta Obstetricia Et Gynecologica Scandinavica. 99(7). 933–940. 19 indexed citations
16.
Oiknine‐Djian, Esther, Shikma Bar-On, Ido Laskov, et al.. (2019). Artemisone demonstrates synergistic antiviral activity in combination with approved and experimental drugs active against human cytomegalovirus. Antiviral Research. 172. 104639–104639. 21 indexed citations
17.
Kogan, Liron, Jeremie Abitbol, Ido Laskov, et al.. (2018). Impact of lower uterine segment involvement in type II endometrial cancer and the unique mutational profile of serous tumors. Gynecologic Oncology Reports. 24. 43–47. 6 indexed citations
18.
Kogan, Liron, Ido Laskov, Jeremie Abitbol, et al.. (2017). Dose dense carboplatin paclitaxel improves progression free survival in patients with endometrial cancer. Gynecologic Oncology. 147(1). 30–35. 10 indexed citations
19.
Laskov, Ido, et al.. (2016). Metformin Increases E-cadherin in Tumors of Diabetic Patients With Endometrial Cancer and Suppresses Epithelial-Mesenchymal Transition in Endometrial Cancer Cell Lines. International Journal of Gynecological Cancer. 26(7). 1213–1221. 26 indexed citations
20.
Laskov, Ido, Laura M. Drudi, Marie‐Claude Beauchamp, et al.. (2014). Anti-diabetic doses of metformin decrease proliferation markers in tumors of patients with endometrial cancer. Gynecologic Oncology. 134(3). 607–614. 84 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ruifang An Breakdown of academic impact, for papers by H Mertens Breakdown of academic impact, for papers by Iztok Takač Breakdown of academic impact, for papers by Mohamad Nasir Shafiee Breakdown of academic impact, for papers by Mehmet Ali Vardar Breakdown of academic impact, for papers by Zhengyu Li Breakdown of academic impact, for papers by Stefanos Zervoudis Breakdown of academic impact, for papers by Norbert Winer Breakdown of academic impact, for papers by Sarikapan Wilailak Breakdown of academic impact, for papers by Kerri S. Bevis
Rankless by CCL
2026